Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast

H Hof1, V Amann2, C Tauber3

  • 1MVZ Labor Limbach, Im Breitspiel 16, 69126, Heidelberg, Germany. herbert.hof@labor-limbach.de.

Infection
|August 22, 2017
PubMed

Insights

A rare yeast, Cyberlindera fabianii, caused a fatal peritoneal infection in a neonate post-heart surgery. The yeast rapidly developed resistance to antifungal drugs, leading to septic shock and multiorgan failure.

Area of Science:

  • Medical Mycology
  • Infectious Diseases

Background:

  • The ascomycetous yeast Cyberlindera fabianii is an environmental organism with occasional pathogenic potential, particularly in neonates.
  • Standard biochemical identification methods often fail for this yeast species.

Observation:

  • A neonate with hypoplastic left heart syndrome developed a peritoneal infection with C. fabianii following congenital heart surgery and transient extracorporeal membrane oxygenation (ECMO).
  • Peritoneal dialysis was initiated due to renal insufficiency, preceding the yeast infection.
  • The source of the C. fabianii infection remained undetermined.

Findings:

  • Accurate identification of C. fabianii was achieved through MALDI-TOF and molecular methods, not standard biochemical tests.
  • Despite initial susceptibility, the yeast rapidly developed resistance to fluconazole, caspofungin, and liposomal amphotericin B during treatment.
  • The patient experienced capillary leak syndrome, septic shock, and multiorgan failure, ultimately succumbing to the infection.

Implications:

  • This case highlights the diagnostic challenges and potential pathogenicity of C. fabianii in vulnerable neonates.
  • Rapid antifungal resistance development in C. fabianii poses a significant therapeutic challenge.
  • Improved diagnostic strategies and understanding of C. fabianii pathogenesis are crucial for managing such rare infections.